Received Jan 12, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | amvb064a | — |
States an expired dose of MENVEO was administered to the patient on 7 JAN 2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 32-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number amvb064a, expiry date 31-DEC-2025) for prophylaxis. Concomitant products included HIB vaccine conj (tet tox) (Hiberix) and meningococcal vaccine B rfhbpa/fhbpb (Trumenba). On 07-JAN-2026, the patient received Menveo. On 07-JAN-2026, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: States an expired dose of MENVEO was administered to the patient on 7 JAN 2025). On 07-JAN-2026, the outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 08-JAN-2026 The administration had occurred on 07-Jan-2025. The issue had come to light during a routine review of vaccine records. The Reporter had confirmed that the product's expiration date had passed before the dose was given.
HIBERIX; TRUMENBA